SMAD3 and aneurysm: The activation of SMAD2 in the nucleus as indicated by the phosphorylated SMAD2 also significantly increased in the aneurysms of Smad3−/− mice using the antibody recognizing phosphorylated SMAD2/3 (Fig. 4C).